期刊
NATURE REVIEWS CANCER
卷 7, 期 11, 页码 870-879出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2247
关键词
-
类别
Gene-directed enzyme-prodrug therapy (GDEPT) aims to improve the therapeutic ratio ( benefit versus toxic side-effects) of cancer chemotherapy. A gene encoding a 'suicide' enzyme is introduced into the tumour to convert a subsequently administered non-toxic prodrug into an active drug selectively in the tumour, but not in normal tissues. Significant effects can now be achieved in vitro and in targeted experimental models, and GDEPT therapies are entering the clinic. Our group has developed a GDEPT system that uses the bacterial enzyme carboxypeptidase G2 to convert nitrogen mustard prodrugs into potent DNA crosslinking agents, and a clinical trial of this system is pending.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据